Insider filing · ELVN
Mika K Derynck
Director
profile →
Enliven Therapeutics, Inc.
ELVN · Healthcare · 61 filings in 24 months
ticker →
Mika K Derynck sold $9.6M of Enliven Therapeutics (ELVN)
Executed Aug 4, disclosed Aug 7, 2 days later.
Value, as filed
$9.6M
158,795 sh × $60.21
Executed
Aug 4
the trade date, as filed
Disclosed
Aug 7
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MDMika K Derynck (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $9.6M of ELVN (158,795 sh × $60.21, as filed), executed Aug 4.
The name
ELVNHealthcare · Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibito…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→